Abscisic acid

Abscisic acid (ABA) is a sesquiterpenoid phytohormone found in plants and trace amounts in certain foods that interacts with the LANCL2 receptor to potentially modulate innate immunity and glucose metabolism. Human clinical evidence remains extremely limited, with no randomized controlled trials confirming therapeutic benefits in humans.

Origin & History

Abscisic acid (ABA) is a sesquiterpenoid plant hormone (C15H20O4) synthesized from carotenoids via the plastidial MEP pathway, found in nearly all plant tissues with highest accumulation under stress conditions like drought or salinity. It is extracted through solvent extraction from plant sources like fruits or leaves, though commercial extraction methods are not standardized for human use.

Historical & Cultural Context

Abscisic acid has no traditional medicine history as it was only identified as a distinct compound in 1963 from sycamore and cotton plants. While plants containing ABA like fruits and potatoes were used historically, ABA itself has no documented traditional applications in any medicine system.

Health Benefits

• No clinically proven health benefits - absence of human randomized controlled trials or meta-analyses
• Potential glycemic control effects suggested by one uncontrolled pilot study (n=10) but showed no significant outcomes
• Possible innate immunity modulation via LANCL2 receptor based on theoretical mechanisms only
• Metabolic effects observed only in preclinical rodent studies at 100-1000 mg/kg doses
• All proposed benefits remain unconfirmed due to complete lack of quality human clinical evidence

How It Works

Abscisic acid binds to the LANCL2 (LanC-like protein 2) receptor, a G-protein-coupled receptor expressed on immune cells and pancreatic beta cells, triggering downstream cAMP and PPAR-gamma signaling pathways. This cascade theoretically promotes GLUT4 translocation and enhances insulin-independent glucose uptake in skeletal muscle and adipose tissue. In immune cells, LANCL2 activation may suppress pro-inflammatory cytokine release via inhibition of NF-kB, though these pathways are characterized primarily in preclinical and in vitro models.

Scientific Research

No large-scale human randomized controlled trials, meta-analyses, or key clinical studies exist for abscisic acid as a therapeutic agent. Research is confined to plant physiology with zero PubMed-indexed RCTs for biomedical applications like diabetes or inflammation. One small uncontrolled pilot study (n=10) explored oral ABA for glycemic control but lacked controls and showed no significant outcomes.

Clinical Summary

Human evidence for abscisic acid is critically sparse. A single uncontrolled pilot study of 10 subjects investigating glycemic control found no statistically significant outcomes following ABA supplementation. No randomized controlled trials, placebo-controlled studies, or meta-analyses exist for any health indication in humans. The majority of supportive data derives from in vitro cell studies and rodent models, making any efficacy claims premature and unsupported by current clinical standards.

Nutritional Profile

Abscisic acid (ABA) is a sesquiterpenoid plant hormone (C15H20O4, molecular weight 264.32 g/mol) and not a traditional nutritional ingredient with macronutrient or micronutrient content. It contains no protein, fiber, fat, or carbohydrate nutritional value. Naturally occurring concentrations in food sources: avocado (~100 ng/g fresh weight), berries (50-150 ng/g), grapes (~30-80 ng/g), and human plasma endogenous levels reported at approximately 1-3 nM under fasting conditions. Bioactive compound classification: abscisic acid functions primarily as a signaling molecule targeting the LANCL2 (LanC-like protein 2) receptor. Estimated dietary intake from whole foods ranges from 10-100 µg/day depending on fruit and vegetable consumption. Bioavailability: oral absorption is reported to be moderate with rapid intestinal uptake suggested in preclinical models; however, human pharmacokinetic data are extremely limited. No established Dietary Reference Intake (DRI), Recommended Daily Allowance (RDA), or Tolerable Upper Intake Level (UL) exists. The compound does not contribute calories. Endogenous synthesis in humans has been proposed but not conclusively demonstrated. Supplement forms typically standardized to synthetic or plant-extracted ABA at concentrations of 100-500 µg per dose, though clinical dosing parameters remain unvalidated.

Preparation & Dosage

No clinically studied dosage ranges exist for humans. Preclinical rodent studies used 100-1000 mg/kg orally, but human equivalents are not established. Commercial supplements, if available, lack clinical validation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

None established - no synergistic compounds studied

Safety & Interactions

The safety profile of supplemental abscisic acid in humans has not been formally established through controlled trials, and no standardized therapeutic dose has been determined. As a modulator of PPAR-gamma and insulin signaling pathways, ABA theoretically carries a risk of additive hypoglycemic effects when combined with antidiabetic medications such as metformin or insulin. Pregnant and breastfeeding women should avoid supplementation entirely due to the complete absence of reproductive safety data. Individuals with autoimmune conditions should exercise caution given its proposed immunomodulatory activity via LANCL2.